Brief Description of the Company
Sandoz is a global leader in generic and biosimilar pharmaceuticals. As a division of the Novartis Group, our purpose is to discover new ways to improve and extend people’s lives. We contribute to society’s ability to support growing healthcare needs by pioneering novel approaches to help people around the world access high-quality medicine.
Our portfolio of approximately 1000 molecules, covering all major therapeutic areas, accounted for 2015 sales of USD 10.1 billion. In 2015, our products reached more than 500 million patients and we aspire to reach one billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.
Sandoz is a reliable brand in Turkey with a strong heritage dating back to the 1950’s. Sandoz has 2 FDF sites in Gebze and 1 API located in Tuzla. Sandoz Turkey is also listed amongst the top exporter in pharmaceutical products since 2005, exporting medicines to 30 countries as well as offering its products for the service of approximately 60 countries. Sandoz’s Gebze plant is ranked first among exporters with an amount of USD 59 million.
Annual Production Capacity
Solid Products: 4,5 billion solids
Semi-solid Products: 10 million packs
Liquid Products: 11 million bottles
Powder suspension: 3,7 million packs
Number of Employees